Comment to “Telaprevir Experience From Turkey”

authors:

avatar Tarik Akar 1 , * , avatar Dilek Malkoc 1 , avatar Selim Aydemir 1

Department of Gastroenterology, School of Medicine, Bulent Ecevit University, Zonguldak, Turkey
Hepatitis Monthly: Vol.15, issue 11; e58820
published online: November 28, 2015
article type: Letter
received: May 12, 2015
accepted: May 22, 2015
DOI: https://doi.org/10.5812/hepatmon.29821

how to cite: Akar T, Malkoc D, Aydemir S. Comment to “Telaprevir Experience From Turkey”. Hepat Mon. 2015;15(11):e58820. https://doi.org/10.5812/hepatmon.29821.

References

  • 1.

    Komur S, Kurtaran B, Inal AS, Pullukcu H, Ulu A, Kuscu F, et al. Telaprevir experience from Turkey. Hepat Mon. 2015;15(2). ee25639. [PubMed ID: 25788959]. https://doi.org/10.5812/hepatmon.25639.

  • 2.

    European Association for Study of L. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2014;60(2):392-420. [PubMed ID: 24331294]. https://doi.org/10.1016/j.jhep.2013.11.003.

  • 3.

    Hezode C, Fontaine H, Dorival C, Larrey D, Zoulim F, Canva V, et al. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol. 2013;59(3):434-41. [PubMed ID: 23669289]. https://doi.org/10.1016/j.jhep.2013.04.035.

  • 4.

    Akar T. Telaprevir-Induced DRESS Syndrome Associated With Salmonella typhi. ACG Case Reports J. 2015;2(2):79. https://doi.org/10.14309/crj.2015.10.

  • 5.

    Rodriguez-Medina B, Blanes M, Vinaixa C, Aguilera V, Rubin A, Prieto M, et al. Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir. Ann Hepatol. 2013;12(6):974-8. [PubMed ID: 24114830].